Invo Bioscience Inc Expected To Post A Loss Of 13 Cents A Share: Earnings Preview

INVO Fertility

12/11/2022 02:25

* INVO Bioscience Inc  INVO.OQ   INVO.O  is expected to show
a
rise in quarterly revenue when it reports  results on November
14. 
    * The Lakewood Ranch Florida-based  company is expected to
report 
a 129.4% increase in revenue to $500 thousand from $218 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for INVO Bioscience Inc
is
for a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2​, above​ its last closing price of $1.13. ​​​

This summary was machine generated November 12 at 02:25 GMT. 
All figures in US dollars  unless otherwise stated